TRAW (Traws Pharma, Inc. Common Stock) Stock Analysis - SEC Filings

Traws Pharma, Inc. Common Stock (TRAW) is a publicly traded Healthcare sector company. As of May 21, 2026, TRAW trades at $1.70 with a market cap of $26.67M and a P/E ratio of -0.94. TRAW moved +3.14% today. Year to date, TRAW is +25.58%; over the trailing twelve months it is +29.60%. Its 52-week range spans $0.97 to $19.44. Rallies surfaces TRAW's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find TRAW SEC filings?

Rallies organizes TRAW SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

TRAW Key Metrics

Key financial metrics for TRAW
MetricValue
Price$1.70
Market Cap$26.67M
P/E Ratio-0.94
EPS$-1.71
Dividend Yield0.00%
52-Week High$19.44
52-Week Low$0.97
Volume3.27K
Avg Volume0
Revenue (TTM)$2.73M
Net Income$-19.43M
Gross Margin0.00%

Latest TRAW News

Recent TRAW Insider Trades

  • ORBIMED ADVISORS LLC bought 597.73K (~$998.21K) on Apr 16, 2026.

TRAW Analyst Consensus

TRAW analyst coverage data. Average price target: $0.00.

Common questions about TRAW

Where can I find TRAW SEC filings?
Rallies organizes TRAW SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show TRAW 10-K and 10-Q filings?
Rallies organizes TRAW SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is TRAW research on Rallies investment advice?
No. Rallies provides research, data, and educational context for TRAW. It does not provide personalized investment advice.
TRAW

TRAW